Table 2.

Echocardiogram findings associated with pulmonary hypertension at 7 days of age and 36 weeks PMA.

	7 days of age (n=188)				36 weeks Post-Menstrual Age (n=180)
	Research Echo Incidence n (%)	Clinical Echo Incidence n (%)	Unreported in Clinical Echo n (%)	Kappa*	Research Echo Incidence n (%)	Clinical Echo Incidence n (%)	Unreported in Clinical Echo n (%)	Kappa*
Cardiac Level or Ductal Shunting	160 (85.1)	168 (89.4)	1(0.5)	0.79	159 (88.3)	152 (84.4)	2 (1.1)	0.74
PDA	68 (36.2)	71 (37.8)	6 (3.2)	0.95	22 (12.2)	27 (15)	15 (8.3)	0.86
ASD/PFO	154 (81.9)	157 (83.5)	6 (3.2)	0.73	140 (77.8)	140 (77.8)	9 (5)	0.80
VSD	5 (2.7)	6 (3.9)	10 (5.3)	0.99	6 (3.3)	7 (3.9)	13 (7.2)	0.99
RA Enlargement	0	2 (1.1)	2 (1.1)	0.98	9 (5)	5 (2.8)	3 (1.7)	0.91
RV Hypertrophy	3 (1.6)	4 (2.1)	48 (25.5)	0.97	5 (2.8)	6 (3.3)	46 (25.6)	0.92
RV Dilation	3 (1.6)	4 (2.1)	3 (1.6)	0.95	16 (8.9)	12 (6.7)	2 (1.1)	0.91
Septal Wall Flattening	59 (31.4)	35 (18.6)	102 (54.3)	0.55	21 (11.7)	24 (13.3)	96 (53.3)	0.86

^*All PABAK values were calculated assuming missing echocardiogram interpretations to be negative or “no”.